IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Strides Arcolab to Up Production

10:00 AM MDT | May 8, 2009

Pharmaceutical firm Strides Arcolab (Bangalore) says it has begun supplying Oseltamivir capsules, the generic equivalent of Roche’s Tamiflu, to various countries for swine flu treatment. Strides Arcolab, one of few approved Oseltamivir manufacturers in India, plans to start producing more than 2 million doses/month in June, as there are only limited stocks currently available, the company says. Strides Arcolab manufactures Oseltamivir at its U.S. FDA-approved and WHO-prequalified facility at Bangalore. “We are particularly well equipped to handle...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa